When most people think about pharmaceutical companies, they’re liking picturing huge corporations that are frequently in the news. For many, huge pharmaceutical companies have become a household name, and they might not even be aware that many pharmaceutical companies are actually small to midsize. Even within the pharmaceutical industry, smaller businesses don’t get the support […]
Read more
Tedor Pharma works every day to produce top-quality pharmaceutical products for our clients. The aspect of our business that separates us from others in the industry is that we see the process through from the early stages to commercialization, rather than focusing on only one aspect of the process and then passing it off to […]
In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. Within the industry itself, of course, we understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. For reference, they mean, respectively, “finished […]
There are many drugs on the market, with new ones being created all the time. With so many pharmaceuticals out there, getting one on the market might seem easier than it actually is. However, developing new medicines is a massive undertaking. This rigorous process is to ensure that pharmaceuticals are effective and safe enough to […]
When you get prescribed medication, or when you buy anything over-the-counter, you expect it to make you feel better. On any drug, you can find a list of risks and side effects, but unless you have a specific reason to be concerned, it likely isn’t something you put much thought into. Many of us can […]
At Tedor Pharma, we enjoy letting potential clients know that we are a full-service pharmaceutical development company. By that, we mean that we are capable of seeing your projects through from formulation to finished product to commercialization. That’s what differentiates us from other CDMOs, or contract development and manufacturing organizations. Instead of focusing all our […]
CUMBERLAND, RI – May 05, 2020 – TEDOR Pharma Inc., www.tedorpharma.com a full-service contract development and manufacturing organization (CDMO), today announced that they entered into an agreement to provide cGMP contract manufacturing services for the Center for International Health Research at Rhode Island Hospital. TEDOR will support a clinical trial that will inform the safety […]
In an exclusive interview with Drug Development and Delivery, Doug Drysdale, President & CEO of TEDOR Pharma, Inc explains how TEDOR is addressing the needs of small- and medium-size companies by developing innovative and repurposed small molecules for unmet medical needs. TEDOR is the exclusive North American provider of FLEXITAB In the interview, Drysdale provides […]
CUMBERLAND, RI – February 19, 2020 – We are pleased to announce that TEDOR Pharma has been chosen as a winner for Providence Business News (PBN) 7th Annual Manufacturing Awards Program for Family-Owned Manufacturer. Companies competing for the award were judged based on confidential surveys and management reports with top honorees being named in a […]
Cumberland, RI – October 8, 2019 – Tedor Pharma, Inc., a full-service contract development and manufacturing organization (CDMO), today announced that they entered into an agreement to provide cGMP contract manufacturing services for Sequential Medicine Ltd.’s triple combination drug product for the short-term treatment of transient insomnia. Sequential Medicine’s product has demonstrated impressive efficacy in early […]
TEDOR expects to gain operational efficiencies for future growth using AssurX platform. Morgan Hill, CA., June 19, 2019 – AssurX, Inc. , a leader in enterprise quality management software today announced that oral solid dose contract development and manufacturing organization (“CDMO”) TEDOR Pharma Inc. has selected the AssurX platform to fully automate their quality and compliance [...]
Adial Reaffirms on Track to Commence Phase 3 Trial in Q3 2019 Charlottesville, VA – June 6, 2019 – Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, and Tedor Pharma, Inc., a full-service contract development and manufacturing organization (CDMO), today announced that they entered [...]
A Significant Investment Towards Advancing Tedor Pharma’s Large Scale Commercial Capabilities.
